HIV-STD Program

Messages to Stakeholders

Funding Opportunity

Learn more about the HIV Prevention funding opportunity.

Program Navigation

Layout
HIV/STD Basics		Healthcare Providers
Get tested for HIV or STDs Testing positive for HIV: what's next? Find medical and support services Get help with medications Learn about PrEP HIV/STD educational materials Learn more about HIV and other STDs		How to report HIV and STDs HIV/STD testing and treatment guidelines Help patients connect with services Help patients get medications Expedited Partner Therapy DSHS Laboratory

DSHS HIV/STD Contractors		Reports, Data, and Policy
HIV prevention HIV medical and support services Routine HIV testing STD prevention and treatment HIV/STD/TB surveillance Funding information Training		HIV/STD Program reports Interactive data: new HIV diagnoses \| people living with HIV \| chlamydia and gonorrhea Data requests Texas HIV/STD laws, rules and authorization Program policies and procedures Planning

Quick Links

layout
HIV Dashboard
Texas HIV/STD Insider
THISIS
HIV and the Workplace
HIV/STD Educational Materials
Texas HIV Syndicate
Medical Monitoring Project (MMP)
Texas Black Women's Initiative
Test Texas HIV Coalition
Syphilis Elimination
Meetings

DSHS Releases Dear Colleague Letter for PrEP

DSHS recently released a Dear Colleague letter detailing the current evidence behind Pre-exposure Prophylaxis (PrEP). Learn more... (PDF : 387 kB)

DSHS Updated PrEP Position Statement

DSHS updated the Pre-Exposure Prophylaxis (PrEP) position statement on January 14, 2019. Learn more...

Notice from DSHS

Most DSHS TB/HIV/STD Section staff have relocated on short notice in the past few months. This quick relocation to temporary office locations have presented challenges. Future staff relocations are planned. We continue to be committed to continuing our programming for prevention, care, and treatment of TB, HIV, and STD.

Recommendations Regarding the Use of Dolutegravir in Adults and Adolescents with HIV who are Pregnant or of Child-Bearing Potential

An NIH-funded observational surveillance study of birth outcomes among pregnant women on antiretroviral therapy in Botswana identified neural tube defects in four infants born to 426 women who initiated a dolutegravir (DTG)-based regimen prior to pregnancy, and who were still receiving it at the time of conception. The U.S. Department of Health and Human Services Antiretroviral Guidelines Panels are issuing recommendations... Learn more [AIDSinfo.gov]

Health Advisory: Rapidly Growing Clusters of Ongoing HIV Transmission in Texas

DSHS encourages Texas healthcare providers to enhance efforts to prevent, diagnose and treat HIV in the wake of 16 rapidly growing clusters of HIV infections in the state. Laboratory analysis of these infections indicates sustained transmission of genetically similar types of HIV... read the Health Advisory: Rapidly Growing Clusters of Ongoing HIV Transmission in Texas (PDF : 327 kB) and read the Molecular HIV Surveillance - Genotype Clusters Talking Points (PDF : 189 kB)

CDC Issues Guidance for Preventing Sexual Transmission of Zika Virus

CDC has issued new interim guidance on preventing sexual transmission of Zika virus... Learn more

Drug Resistant Gonorrhea on the Rise

Gonorrhea is developing a resistance to the last classes of drugs available in the U.S. that are able to cure infection... Learn more

This site contains HIV or STD messages that may not be deemed appropriate for all audiences. Since HIV and other STDs are spread primarily through sexual practices or by sharing needles, messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this web site. Photos on this website are all posed by a model.